Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer

by Cancello, Giuseppe, Montagna, Emilia, D'Agostino, Diego, Giuliano, Mario, Giordano, Antonio, Di Lorenzo, Giuseppe, Plaitano, Monica, De Placido, Sabino, De Laurentiis, Michele
Published 2008

Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives

by Criscitiello, Carmen, André, Fabrice, Thompson, Alastair M, De Laurentiis, Michele, Esposito, Angela, Gelao, Lucia, Fumagalli, Luca, Locatelli, Marzia, Minchella, Ida, Orsi, Franco, Goldhirsch, Aron, Curigliano, Giuseppe
Published 2014

Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of dif...

by Del Mastro, Lucia, Fabi, Alessandra, Mansutti, Mauro, De Laurentiis, Michele, Durando, Antonio, Merlo, Domenico Franco, Bruzzi, Paolo, La Torre, Ignazia, Ceccarelli, Matteo, Kazeem, Gbenga, Marchi, Paolo, Boy, Davide, Venturini, Marco, De Placido, Sabino, Cognetti, Francesco
Published 2013

Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study

by Fasching, Peter A., Beck, J. Thaddeus, Chan, Arlene, De Laurentiis, Michele, Esteva, Francisco J., Jerusalem, Guy, Neven, Patrick, Pivot, Xavier, Bianchi, Giulia V., Martin, Miguel, Chandiwana, David, Lanoue, Brad, Ridolfi, Antonia, Wang, Yingbo, Rodriguez Lorenc, Karen, Nusch, Arnd
Published in Breast (2020)

Epithelial-Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer

by Giordano, Antonio, Gao, Hui, Anfossi, Simone, Cohen, Evan, Mego, Michal, Lee, Bang-Ning, Tin, Sanda, De Laurentiis, Michele, Parker, Charla A., Alvarez, Ricardo H., Valero, Vicente, Ueno, Naoto T., De Placido, Sabino, Mani, Sendurai A., Esteva, Francisco J., Cristofanilli, Massimo, Reuben, James M.
Published 2012

Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DEDiCa): design of a clinical trial

by Augustin, Livia S.A., Libra, Massimo, Crispo, Anna, Grimaldi, Maria, De Laurentiis, Michele, Rinaldo, Massimo, D’Aiuto, Massimiliano, Catalano, Francesca, Banna, Giuseppe, Ferrau’, Francesco, Rossello, Rosalba, Serraino, Diego, Bidoli, Ettore, Massarut, Samuele, Thomas, Guglielmo, Gatti, Davide, Cavalcanti, Ernesta, Pinto, Monica, Riccardi, Gabriele, Vidgen, Edward, Kendall, Cyril W.C., Jenkins, David J.A., Ciliberto, Gennaro, Montella, Maurizio
Published in BMC Cancer (2017)

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blin...

by Baselga, José, Im, Seock-Ah, Iwata, Hiroji, Cortés, Javier, De Laurentiis, Michele, Jiang, Zefei, Arteaga, Carlos L, Jonat, Walter, Clemons, Mark, Ito, Yoshinori, Awada, Ahmad, Chia, Stephen, Jagiello-Gruszfeld, Agnieszka, Pistilli, Barbara, Tseng, Ling-Ming, Hurvitz, Sara, Masuda, Norikazu, Takahashi, Masato, Vuylsteke, Peter, Hachemi, Soulef, Dharan, Bharani, Di Tomaso, Emmanuelle, Urban, Patrick, Massacesi, Cristian, Campone, Mario
Published in Lancet Oncol (2017)